GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (CHIX:MRKd) » Definitions » Cyclically Adjusted Revenue per Share

Merck KGaA (CHIX:MRKD) Cyclically Adjusted Revenue per Share : €43.68 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Merck KGaA Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Merck KGaA's adjusted revenue per share for the three months ended in Mar. 2024 was €11.804. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €43.68 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Merck KGaA's average Cyclically Adjusted Revenue Growth Rate was 6.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Merck KGaA was 10.70% per year. The lowest was 5.40% per year. And the median was 8.60% per year.

As of today (2024-06-06), Merck KGaA's current stock price is €168.35. Merck KGaA's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €43.68. Merck KGaA's Cyclically Adjusted PS Ratio of today is 3.85.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Merck KGaA was 6.52. The lowest was 2.74. And the median was 3.63.


Merck KGaA Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Merck KGaA's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Cyclically Adjusted Revenue per Share Chart

Merck KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.79 32.12 36.04 40.58 42.45

Merck KGaA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.77 42.32 43.47 42.45 43.68

Competitive Comparison of Merck KGaA's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck KGaA's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Merck KGaA's Cyclically Adjusted PS Ratio falls into.



Merck KGaA Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Merck KGaA's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=11.804/125.0381*125.0381
=11.804

Current CPI (Mar. 2024) = 125.0381.

Merck KGaA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 6.498 99.543 8.162
201409 6.691 99.823 8.381
201412 6.856 99.543 8.612
201503 7.009 99.717 8.789
201506 7.414 100.417 9.232
201509 7.200 100.417 8.965
201512 7.961 99.717 9.983
201603 8.434 100.017 10.544
201606 8.781 100.717 10.901
201609 8.556 101.017 10.591
201612 8.823 101.217 10.899
201703 8.859 101.417 10.922
201706 8.500 102.117 10.408
201709 8.083 102.717 9.839
201712 8.393 102.617 10.227
201803 7.974 102.917 9.688
201806 8.571 104.017 10.303
201809 8.601 104.718 10.270
201812 8.996 104.217 10.793
201903 8.523 104.217 10.226
201906 9.133 105.718 10.802
201909 9.337 106.018 11.012
201912 10.007 105.818 11.825
202003 10.062 105.718 11.901
202006 9.474 106.618 11.111
202009 10.220 105.818 12.076
202012 10.552 105.518 12.504
202103 10.663 107.518 12.401
202106 11.201 108.486 12.910
202109 11.436 109.435 13.067
202112 12.004 110.384 13.598
202203 11.932 113.968 13.091
202206 12.807 115.760 13.833
202209 13.336 118.818 14.034
202212 13.040 119.345 13.662
202303 12.169 122.402 12.431
202306 12.195 123.140 12.383
202309 11.900 124.195 11.981
202312 12.000 123.773 12.123
202403 11.804 125.038 11.804

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Merck KGaA  (CHIX:MRKd) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Merck KGaA's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=168.35/43.68
=3.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Merck KGaA was 6.52. The lowest was 2.74. And the median was 3.63.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Merck KGaA Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck KGaA (CHIX:MRKD) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (CHIX:MRKd) » Definitions » Cyclically Adjusted Revenue per Share
Address
Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Merck KGaA (CHIX:MRKD) Headlines

No Headlines